{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:52:39Z","timestamp":1784076759240,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":739,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.bbmt.2013.01.011","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T18:03:21Z","timestamp":1358445801000},"page":"607-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Distinct Clinical Features of Infectious Complications in Adult T Cell Leukemia\/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis in the Nagasaki Transplant Group"],"prefix":"10.1016","volume":"19","author":[{"given":"Hidehiro","family":"Itonaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sawayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reishi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Onimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiyoshi","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumihisa","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.01.011_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib2","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Sci USA"},{"key":"10.1016\/j.bbmt.2013.01.011_bib3","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2013.01.011_bib4","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","article-title":"Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease","volume":"81","author":"Yoshida","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2013.01.011_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma: A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.01.011_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A\u00a0new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.01.011_bib7","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2013.01.011_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1702731","article-title":"Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Utsunomiya","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2141.2003.04054.x","article-title":"Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukemia\/lymphoma","volume":"120","author":"Kami","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.01.011_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.leu.2403682","article-title":"Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma","volume":"19","author":"Fukushima","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.01.011_bib11","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2004-11-4193","article-title":"Allogeneic stem-cell transplantation with reduced intensity as novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma","volume":"105","author":"Okamura","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbmt.2006.09.002","article-title":"Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-1-negative donors for adult T-cell leukemia\/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program","volume":"13","author":"Kato","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbmt.2008.03.010","article-title":"Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T-cell leukemia\/lymphoma: impact of antithymocyte globulin on clinical outcome","volume":"14","author":"Tanosaki","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib14","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib15","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1182\/blood-2011-07-368233","article-title":"Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study","volume":"119","author":"Kanda","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib16","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study","volume":"120","author":"Ishida","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib17","doi-asserted-by":"crossref","unstructured":"Itonaga H, Tsushima H, Taguchi J, et\u00a0al. Treatment of relapsed adult T-cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience. Blood doi:10.1182\/blood-2012-07-444372.","DOI":"10.1182\/blood-2012-07-444372"},{"key":"10.1016\/j.bbmt.2013.01.011_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/10428199309087005","article-title":"Autopsy findings in 47 cases of adult T-cell leukemia\/lymphoma in Miyazaki prefecture","volume":"11","author":"Suzumiya","year":"1993","journal-title":"Japan. Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2013.01.011_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","article-title":"Human T cell leukemia virus type I (HTLV-I) and human diseases","volume":"15","author":"Uchiyama","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bbmt.2013.01.011_bib20","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1182\/blood.V97.10.3177","article-title":"Impaired production of na\u00efve T\u00a0lymphocytes in human T-cell leukemia virus type I-infected individuals: Its implications in the immunodeficient state","volume":"97","author":"Yasunaga","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/intimm\/dxh366","article-title":"Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells","volume":"18","author":"Chen","year":"2006","journal-title":"Int Immunol"},{"key":"10.1016\/j.bbmt.2013.01.011_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/jmv.22013","article-title":"High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia","volume":"83","author":"Ogata","year":"2011","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.bbmt.2013.01.011_bib23","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib25","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20142009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/bmt.2009.257","article-title":"Bacterial prevention after hematopoietic cell transplantation","volume":"44","author":"Engelhard","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bmt.1703214","article-title":"Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"28","author":"Kanda","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V99.6.1978","article-title":"Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with Myeloabrative allogeneic stem cell transplantation, a matched control study","volume":"99","author":"Junghanss","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib30","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063","article-title":"Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation:\u00a0a randomized double-blind study","volume":"88","author":"Boeckh","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib31","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood.V93.5.1781","article-title":"Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients","volume":"93","author":"Boekh","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1442-200X.2009.03005.x","article-title":"Seroepidemilogical survey of cmytpmegalovirus infection among pregnant women in Nagasaki, Japan","volume":"52","author":"Tagawa","year":"2010","journal-title":"Pediatr Int"},{"key":"10.1016\/j.bbmt.2013.01.011_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jmv.1890370413","article-title":"Prospective study on maternal, intrauterine, and perinatal infections with cytomegalovirus in Japan during 1976-1990","volume":"37","author":"Hirota","year":"1992","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.bbmt.2013.01.011_bib34","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood.V86.9.3598.bloodjournal8693598","article-title":"A\u00a0comparison of filtered leukocyte-reduced and cytomegalovirus seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant","volume":"86","author":"Bowden","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2013.01.011_bib36","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2013.01.011_bib37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/319352","article-title":"Adenovirus infections in adult recipients of blood and marrow transplants","volume":"32","author":"La Rosa","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2013.01.011_bib38","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V98.6.1971","article-title":"Quantification of polyoma BK viruria in hemorrhagic cystis complicating bone marrow transplantation","volume":"8","author":"Leung","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib39","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V78.5.1381.1381","article-title":"Human herpesvirus-6 infection in bone marrow transplantation","volume":"78","author":"Yoshikawa","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib40","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetic on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children\u2019s Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1365-2141.2003.03981.x","article-title":"Cytogenetic heterogenecity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 study","volume":"120","author":"Miyazaki","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.01.011_bib42","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2007.06.006","article-title":"Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources","volume":"13","author":"Walker","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib43","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V95.7.2240","article-title":"Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation","volume":"95","author":"Broers","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib44","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.bbmt.2007.08.049","volume":"13","author":"van Burik","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib45","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: change in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib46","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s12185-010-0597-6","article-title":"Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in\u00a0vivo T cell depletion","volume":"9","author":"Schmidt-Hieber","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2013.01.011_bib47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1399-3062.2009.00414.x","article-title":"Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin","volume":"11","author":"Park","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2013.01.011_bib48","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/sj.leu.2403105","article-title":"Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen","volume":"17","author":"Mohty","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.01.011_bib49","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/bmt.2010.272","article-title":"High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts","volume":"46","author":"Hoegh-Petersen","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib50","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa041276","article-title":"Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia","volume":"351","author":"Laughlin","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2013.01.011_bib51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbmt.2007.02.012","article-title":"invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases","volume":"13","author":"Miyakoshi","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib52","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood.V100.6.2005","article-title":"High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplants","volume":"100","author":"Sashihara","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.011_bib53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bbmt.2006.12.454","article-title":"Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients","volume":"13","author":"Matsumura","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib54","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbmt.2009.03.002","article-title":"Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation","volume":"15","author":"Montesinos","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbmt.2003.08.011","article-title":"Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment","volume":"10","author":"Nakamura","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.011_bib56","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/infdis\/156.6.899","article-title":"Immunosuppressive effects of ganciclovir on in\u00a0vitro lymphocyte responses","volume":"156","author":"Bowden","year":"1987","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2013.01.011_bib57","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/PL00000625","article-title":"Generalized immunosuppression: how viruses underline the immune response","volume":"57","author":"Naniche","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bbmt.2013.01.011_bib58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/00365540500440353","article-title":"\u2018Break-point Checkerboard Plate\u2019 for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa","volume":"38","author":"Tateda","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.bbmt.2013.01.011_bib59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/00365540903443157","article-title":"Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a \u2018break-point checkerboard plate\u2019","volume":"42","author":"Araoka","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.bbmt.2013.01.011_bib60","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jac\/dkn530","article-title":"Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa","volume":"63","author":"Aoki","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.bbmt.2013.01.011_bib61","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s15010-009-8342-x","article-title":"Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections","volume":"37","author":"Montero","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.bbmt.2013.01.011_bib62","article-title":"Evaluation in\u00a0vitro of the efficacy of colistin methanesulfonate against biofilm-forming multidrug-resistant Pseudomonas aeruginosa (MDRP)","author":"Marumo","year":"2012","journal-title":"J\u00a0Infect Chemother"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:44:03Z","timestamp":1761057843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1083879113000268"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.011","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct Clinical Features of Infectious Complications in Adult T Cell Leukemia\/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis in the Nagasaki Transplant Group","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}